Human papillomavirus (HPV) infection in women participating in cervical cancer screening from 2006 to 2010 in Shenzhen City, South China

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7483-7487

  Wang, Yue Yun ^a   Li, Li ^b   Wei, Sheng ^b   Peng, Ji ^c   Yuan, Shi Xin ^a   Xie, Jian Sheng ^a   Liu, Zhi Hua ^a  

^a Maternal and Children's Health Hospital of Shenzhen City   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Shen Zhen Center for Chronic Disease Control   (China)

Author keywords

Cervical cancer; China; Epidemiology; Human papilloma virus; Subtype

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CHINA; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; TIME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84893392538     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7483     Document Type: Article

References (31)

1. Bao YP, Li N, Smith JS, et al (2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer, 18, 71-9.
2. Bao YP, Li N, Wang H, et al (2007). Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis. Zhonghua Liu Xing Bing Xue Za Zhi, 28, 941-6 (in Chinese).
3. Bernard E, Pons-Salort M, Favre M, et al (2013). Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis, 13, 373.
4. Bosch FX, Sanjose S (2003). Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr, 31, 3-13.
5. Bosch FX, Lorincz A, Munoz N, et al (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65.
6. Bosch FX, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802.
7. Carter JJ, Koutsky LA, Hughes JP, et al (2000). Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis, 181, 1911-9.
8. Cavalcanti SM, Deus FC, Zardo LG, et al (1996). Human papillomavirus infection and cervical cancer in Brazil: a retrospective study. Mem Inst Oswaldo Cruz, 91, 433-40.
9. Chaturvedi AK, Katki HA, Hildesheim A, et al (2011). Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis, 203, 910-20.
10. Cibas ES, Hong X, Crum CP, Feldman S (2007). Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Gynecol Oncol, 104, 702-6.
11. Clifford G, Franceschi S, Diaz M, et al (2006). Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24, S3/26-34.
12. Clifford GM, Smith JS, Aguado T, et al (2003). Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, 89, 101-5.
13. Datta P, Bhatla N, Dar L, et al (2010). Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol, 34, 157-61.
14. Einstein MH, Goldberg G L (2002). Human papillomavirus and cervical neoplasia. Cancer Invest, 20, 1080-5.
15. Figueroa JP, Ward E, Luthi TE, et al (1995). Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis, 22, 114-8.
16. Garland S, Park SN, Ngan HY, et al (2008). The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference. Vaccine, 26, 5435-40.
17. Guido M, Tinelli A, De Donno A, et al (2013). Prevalence and distribution of human papillomavirus genotype in south eastern Italy, in the period 2006-2011: implications for intervention. Curr Pharm Des, 19, 1498-507.
18. Hibbitts S, Jones J, Powell N, et al (2008). Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer, 99, 1929-33.
19. Hwang TS, Jeong JK, Park M, et al (2003). Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol, 90, 51-6.
20. Liu M, Wang CX, Deng XM, et al (2007). Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province. Zhonghua Liu Xing Bing Xue Za Zhi, 28, 487-90 (in Chinese).
21. Mejlhede N, Bonde J, Fomsgaard A, et al (2009). High frequency of multiple HPV types in cervical specimens from Danish women. APMIS, 117, 108-14.
22. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
23. Nielsen A, Kjaer SK, Munk C, et al (2008). Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis, 35, 276-82.
24. Oh JK, Franceschi S, Kim BK, et al (2009). Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev, 18, 56-61.
25. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
26. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
27. Wang CH, Garvilles RG, Chen CY, et al (2010). Characterization of human papillomavirus infection in north Taiwan. J Med Virol, 82, 1416-23.
28. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A (2000). HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA, 283, 81-6.
29. Wu EQ, Liu B, Cui JF, et al (2013). Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control, 24, 795-803.
30. Wu Y, Chen Y, Li L, et al (2006). Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 35, 264-9.
31. Hausen H, (1996). Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta, 1288, F55-78.